Literature DB >> 21985026

Hypoxia-inducible factor pathway activation in restless legs syndrome patients.

S M Patton1, P Ponnuru, A M Snyder, G D Podskalny, J R Connor.   

Abstract

BACKGROUND AND
PURPOSE: These studies tested the hypothesis that hypoxia inducible factor-1α (HIF-1α) pathway activation occurs in substantia nigra neurons and brain microvasculature in patients with restless legs syndrome.
METHODS: Immunohistochemical analyses of substantia nigra tissue from six RLS and six control subjects were analyzed for HIF-1α, neuronal nitric oxide synthase (nNOS) and nitrotyrosine immunoreactivity. Microvessel lysates were obtained from cortex tissue from four RLS and four control subjects and the lysates were quantified for HIF-2α and vascular endothelial growth factor (VEGF) expression using immunoblot analyses. HIF-1α activation of peripheral blood monocyte cells (PBMCs) (14 RLS and 9 control) was determined through immunoblot analysis of PBMC lysates for EPO.
RESULTS: HIF-1α immunoreactivity in substantia nigra neurons was significantly increased in five of six RLS patients as compared with controls. In addition, nNOS and nitrotyrosine expression are up-regulated in the substantia nigra of four of six RLS patients as compared with controls. HIF-2α and VEGF expression are significantly up-regulated in the microvasculature lysates from four RLS cortical brain tissue as compared with controls. Erythropoietin levels are significantly increased in RLS PBMCs.
CONCLUSIONS: These results demonstrate that the hypoxia pathway is activated in multiple cell types in individuals with RLS. Increased nNOS and nitrotyrosine suggests that nitric oxide is involved in the activation. Activation of the hypoxia pathway can result from or contribute to cellular iron deficiency. These observations suggest a novel direction to explore in RLS that is tied to the iron deficiency model but better explains the findings in postmortem studies.
© 2011 The Author(s). European Journal of Neurology © 2011 EFNS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985026     DOI: 10.1111/j.1468-1331.2011.03397.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  30 in total

Review 1.  Restless legs syndrome and pregnancy: prevalence, possible pathophysiological mechanisms and treatment.

Authors:  R Gupta; M Dhyani; T Kendzerska; S R Pandi-Perumal; A S BaHammam; P Srivanitchapoom; S Pandey; M Hallett
Journal:  Acta Neurol Scand       Date:  2015-10-19       Impact factor: 3.209

2.  Impaired endothelial function may predict treatment response in restless legs syndrome.

Authors:  Min Seung Kim; Dong Gyu Park; Jung Han Yoon
Journal:  J Neural Transm (Vienna)       Date:  2019-06-19       Impact factor: 3.575

3.  [Practical guidelines for diagnosis and therapy of restless legs syndrome].

Authors:  M Krenzer; W Oertel; C Trenkwalder
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

4.  Association of incident restless legs syndrome with outcomes in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Jun L Lu; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Sleep Res       Date:  2016-02       Impact factor: 3.981

5.  Incidence of restless legs syndrome and its correlates.

Authors:  Pooja Budhiraja; Rohit Budhiraja; James L Goodwin; Richard P Allen; Anne B Newman; Brian B Koo; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

6.  Restless legs syndrome is associated with mast cell activation syndrome.

Authors:  Leonard B Weinstock; Arthur S Walters; Jill B Brook; Zahid Kaleem; Lawrence B Afrin; Gerhard J Molderings
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

7.  Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome.

Authors:  Ceyhun Varım; Bilgehan Atılgan Acar; Mehmet Sevki Uyanık; Turkan Acar; Neslihan Alagoz; Ahmet Nalbant; Tezcan Kaya; Hasan Ergenc
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

8.  Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-07-31       Impact factor: 3.332

9.  Treatment of Comorbid Obstructive Sleep Apnea by Upper Airway Stimulation Results in Resolution of Debilitating Symptoms of Restless Legs Syndrome.

Authors:  Lukasz A Myc; Ian T Churnin; Mark J Jameson; Eric M Davis
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

Review 10.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.

Authors:  Richard P Allen
Journal:  Sleep Med Clin       Date:  2015-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.